https://www.pharmaceutical-business-review.com/news/thallion-pharma-q3-revenue-rises_131010/ 2010-10-13T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-hires-new-chemical-development-vice-president_131010/ 2010-10-13T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/allos-therapeutics-releases-folotyn-phase-2b-study_131010/ 2010-10-13T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/caliper-life-sciences-agilent-technologies-renew-microfluidic-chips-supply-agreement_131010/ 2010-10-13T04:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/business-review-webinar-to-discuss-potential-pharma-manufacturing-locations-in-us_131010/ 2010-10-13T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-noa-to-watson-pharma-key-progesterone-preterm-birth-patent_131010/ 2010-10-13T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-forges-license-agreement-with-synosia-for-neurology-compounds_131010/ 2010-10-13T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lithera-gets-noa-from-uspto-for-lipo-102_131010/ 2010-10-13T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cydex-pharma-prism-to-terminate-joint-development-agreement_131010/ 2010-10-13T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/b-braun-medical-unveils-cefepime-for-use-in-duplex-drug-delivery-system_131010/ 2010-10-13T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/tryton-medical-recruits-first-patient-in-e-tryton-italy-study_131010/ 2010-10-13T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-gets-milestone-payment-from-boehringer-ingelheim_131010/ 2010-10-13T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/secure-file-transfer-aids-accelerate-pharma-product-development-accellion_141010/ 2010-10-13T19:35:00+00:00 https://www.pharmaceutical-business-review.com/news/baxa-enhances-doseedge-system-with-formulary-information/ 2010-10-13T22:46:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-selects-medidata-rave-for-dermatology-trials_141010/ 2010-10-13T22:50:00+00:00 https://www.pharmaceutical-business-review.com/news/veeva-systems-salesforcecom-expand-alliance-to-serve-global-pharma-biotech-industries_141010/ 2010-10-14T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-gets-european-approval-cyanokit-5g-presentation_141010/ 2010-10-14T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/china-ruitai-gets-cellulose-ether-contract-from-pharma-company_141010/ 2010-10-14T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-develops-new-ict-107-manufacturing-method_141010/ 2010-10-14T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/natural-health-science-pycnogenol-effective-against-tinnitus_131010/ 2010-10-14T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ortho-biotech-releases-cou-aa-301-study-results_141010/ 2010-10-14T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hepi-gets-paz-patent-issuance-notification_141010/ 2010-10-14T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-h-lundbeck-sign-antibody-development-agreement_141010/ 2010-10-14T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/galenea-receives-nimh-grant-to-advance-mantra-technology-platform_141010/ 2010-10-14T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalink-nefecon-receives-fda-orphan-drug-designation/ 2010-10-14T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-introduces-postmenopausal-osteoporosis-drug-viviant-in-japan-spain_141010/ 2010-10-14T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-pharma-to-relocate-headquarters-to-durham_141010/ 2010-10-14T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/santhera-licenses-mc-4r-antagonist-program-to-biolinerx_141010/ 2010-10-14T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/york-label-pago-group-forge-global-alliance_141010/ 2010-10-14T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/memory-loss-confusion-personal-safety-top-concerns-for-ad-caregivers-harris-interactive_141010/ 2010-10-14T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/bioscale-names-vice-president-of-finance-administration_141010/ 2010-10-14T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/twilight-litaka-pharma-to-offer-technical-know-how-to-interpro-healthcare_151010/ 2010-10-14T23:19:00+00:00 https://www.pharmaceutical-business-review.com/news/loestrin-24-fe-and-femcon-fe-patent-litigations_151010/ 2010-10-15T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-pharma-q3-total-net-revenues-rise-13_151010/ 2010-10-15T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-insight-presents-phase-1-clinical-trials-data-comparing-trofex-prostascint_151010/ 2010-10-15T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/surmodics-realigns-organisational-structure_151010/ 2010-10-15T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/pdr-network-the-doctors-company-partner-for-rems-cme-programs_151010/ 2010-10-15T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bd-opens-new-bioscience-production-facility-in-miami_151010/ 2010-10-15T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/startech-makes-texas-emerging-technology-fund-investment-in-viroxis_151010/ 2010-10-15T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/prolong-pharma-secures-funding-for-anemia-treatment_151010/ 2010-10-15T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-names-new-vice-president-for-product-development_151010/ 2010-10-15T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-talecris-biotherapeutics-gamunex-c_151010/ 2010-10-15T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-gabitril-rems-gets-fda-approval_151010/ 2010-10-15T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/zenith-pharma-sells-stake-in-strides-arcolab_151010/ 2010-10-15T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/epocrates-hires-new-coo_181010/ 2010-10-17T19:12:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-lansoprazole-delayed-release-capsules-get-fda-approval_181010/ 2010-10-17T23:23:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-laboratories-generic-lotrel-anda-gets-fda-approval_181010/ 2010-10-18T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/d-medical-selects-pharmaserve-lilly-as-distribution-partner-in-greece_181010/ 2010-10-18T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-generic-versions-of-hyzaar-cozaar_181010/ 2010-10-18T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/teriflunomide-reduces-relapses-in-ms-patients-sanofi-aventis_181010/ 2010-10-18T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/syndax-gets-uk-patent-for-entinostat_181010/ 2010-10-18T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approval-for-repository-corticotropin-injection-hp-acthar-gel_181010/ 2010-10-18T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ista-bromday-solution_181010/ 2010-10-18T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/aclasta-preserves-bone-mass-in-postmenopausal-osteoporosis-novartis_181010/ 2010-10-18T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-phebra-launch-acetadote-in-australia_181010/ 2010-10-18T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/west-ward-mutual-pharmaceutical-resolve-oral-colchicine-tablets-dispute-hikma/ 2010-10-18T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-pharma-presents-sildenafil-citrate-oral-spray-formulation-study-results_181010/ 2010-10-18T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/liquent-inks-strategic-partnership-with-esa_191010/ 2010-10-18T18:46:00+00:00 https://www.pharmaceutical-business-review.com/news/mcneil-consumer-healthcare-recalls-tylenol-8-hour-caplets-lot_181010/ 2010-10-19T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-teva-anda-to-market-generic-prevacid-solutab-_191010/ 2010-10-19T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/spectra-analysis-instruments-offers-discovir-lc-ftir-technology_191010/ 2010-10-19T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-in-research-pact-with-nrc-_191010/ 2010-10-19T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-concludes-almac-uk-site-inspection_191010/ 2010-10-19T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-signs-biopharmaceutical-development-manufacturing-agreement/ 2010-10-19T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/neurogesx-to-pursue-us-label-expansion-for-qutenza_191010/ 2010-10-19T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-baraclude-snda-gets-fda-nod_191010/ 2010-10-19T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/biocon-pfizer-sign-global-insulin-commercialisation-pact_191010/ 2010-10-19T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-in-research-pact-with-harvard-university-_181010/ 2010-10-19T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/stb-lifesaving-technologies-completes-fast-pre-ind-submission_191010/ 2010-10-19T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-selects-second-therapeutic-antibody-program-with-novartis_191010/ 2010-10-19T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-chooses-veeva-crm-for-global-deployments_191010/ 2010-10-19T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-to-transfer-intal-manufacturing-rights-to-sanofi-aventis_191010/ 2010-10-19T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/given-imaging-introduces-pillcam-express-pillcam-sb-2-ex/ 2010-10-19T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/stirling-pharma-receives-site-license-for-manufacturing-facility-in-canada_191010/ 2010-10-19T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-noa-for-use-of-inhaled-interferon-beta-synairgen-_191010/ 2010-10-19T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/np2-enkephalin-phase-i-trial-shows-pain-reduction-diamyd-medical_191010/ 2010-10-19T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/agile-names-new-president-ceo_191010/ 2010-10-19T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-fast-track-status-to-aastrom-cli-cell-therapy-development-program-_191010/ 2010-10-19T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-files-topical-interferon-alpha-2b-ind-application_191010/ 2010-10-19T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/zydus-cadila-reports-21-increase-in-q2-2010-net-sales_191010/ 2010-10-19T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/progenics-pharma-selects-medidata-rave-edc-cdm-platform_201010/ 2010-10-19T17:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-q3-revenues-up-8_201010/ 2010-10-19T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-rolls-out-inavir-dry-powder-inhaler_201010/ 2010-10-20T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-q3-revenues-increase-marginally_201010/ 2010-10-20T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/amp-ima-tube-filling-line-gets-commercial-manufacturing-approval_201010/ 2010-10-20T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-lilly-alkermes-bydureon-nda-gets-complete-response-letter_201010/ 2010-10-20T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-solubest-sign-technology-development-agreement-_201010/ 2010-10-20T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ppg-industries-acquires-packaging-coatings-company-bairun_201010/ 2010-10-20T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/en-ze-jia-shi-pharmaceuticals-gets-patent-for-gliclazide-preparation-methods-201010/ 2010-10-20T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-life-sciences-allist-in-pbi-1402-pbi-4419-commercialisation-agreement_201010/ 2010-10-20T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/adolor-commences-adl5945-phase-2-trial-in-oic-patients_201010/ 2010-10-20T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chugai-pharma-presents-eldecalcitol-phase-iii-trial-results_201010/ 2010-10-20T02:40:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ec-grants-orphan-drug-status-to-ipsen-obi-1_201010/ 2010-10-20T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/immupharma-initiates-cancer-compund-ipp-204106-phase-iia-trial_201010/ 2010-10-20T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/mannkind-doses-first-patient-in-mkc1106-mt-phase-2-trial_201010/ 2010-10-20T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/althea-technologies-completes-prefilled-syringe-line-installation_191010/ 2010-10-20T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-pradaxa-gets-fda-nod_201010/ 2010-10-20T03:43:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-pharma-takes-over-lumacan-rights-from-photocure_201010/ 2010-10-20T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-files-azilsartan-medoxomil-maa-with-ema_201010/ 2010-10-20T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/cytheris-starts-eramune-01-trial_201010/ 2010-10-20T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/igps-launches-new-pallet-rental-service-for-pharma-life-sciences-industries_201010/ 2010-10-20T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mirna-therapeutics-receives-uspto-notice-of-allowance_201010/ 2010-10-20T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/optinose-presents-results-on-fluticasone_211010/ 2010-10-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prometheus-research-forms-prometheus-solutions-group_211010/ 2010-10-20T19:31:00+00:00 https://www.pharmaceutical-business-review.com/news/hcplexus-partners-healthline-networks_211010/ 2010-10-20T20:20:00+00:00 https://www.pharmaceutical-business-review.com/news/diamedica-names-new-vice-president-of-finance_211010/ 2010-10-20T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/alcon-q3-sales-increase_211010/ 2010-10-20T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-q3-net-sales-up-118_211010/ 2010-10-20T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-breakyl-receives-european-approval_211010/ 2010-10-20T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/delcath-makes-key-appointments-in-rd_211010/ 2010-10-20T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-lilly-teplizumab-phase-3-trial-primary-endpoint-unmet_211010/ 2010-10-21T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-revenues-rise-in-q3_211010/ 2010-10-21T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/healthsport-cure-pharmaceutical-sign-loi_211010/ 2010-10-21T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ingenuity-systems-transmed-systems-integrate-software-for-personalised-medicine-research_211010/ 2010-10-21T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-net-sales-climb-13-in-q3-_211010/ 2010-10-21T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-reveals-classic-i-phase-3-trial-results_211010/ 2010-10-21T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-take-over-40-stake-in-brazilian-otc-firm-teuto_211010/ 2010-10-21T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/agensys-seattle-genetics-initiate-prostate-cancer-drug-phase-1-clinical-trial_211010/ 2010-10-21T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/quark-pharma-doses-first-patient-in-naion-phase-1-trial-_211010/ 2010-10-21T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/aradigm-orbit-2-trial-meets-primary-secondary-endpoints_211010/ 2010-10-21T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/biofrontera-begins-belixos-shipping-to-mena-region_211010/ 2010-10-21T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharma-submits-patent-applications-for-cobalamin-oral-delivery-technology_211010/ 2010-10-21T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/xenogenics-acquires-ideal-biostent-assets_211010/ 2010-10-21T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/sxc-signs-three-year-pharmacy-benefit-management-contract_211010/ 2010-10-21T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotune-presents-positive-dimiracetam-phase-iia-results_211010/ 2010-10-21T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-inaugurates-new-service-operations-center-in-india_221010/ 2010-10-21T20:54:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-unveils-pirfenidone-for-ipf-patients-in-india-_221010/ 2010-10-21T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/jennerex-hires-new-senior-vice-president-for-technical-operations_221010/ 2010-10-22T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-metastatic-stomach-cancer-drug-herceptin-gets-fda-approval_221010/ 2010-10-22T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-challenge-to-levofloxacin-patent-term-extension-in-us-fails_221010/ 2010-10-22T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-names-new-leader-of-bioduro_221010/ 2010-10-22T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-antimicrobial-compound-lor-220-gets-us-patent-allowance_221010/ 2010-10-22T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-voluntarily-recalls-fentanyl-transdermal-system-25mcghour_221010/ 2010-10-22T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-q3-revenues-rise-marginally_221010/ 2010-10-22T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-offers-piperacillin-tazobactam-for-injection-in-us_221010/ 2010-10-22T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-gets-milestone-payment-from-janssen-pharmaceutica_221010/ 2010-10-22T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-cayston-phase-iii-trial-meets-co-primary-endpoint_221010/ 2010-10-22T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-pramipexole-dihydrochloride-tablets-_221010/ 2010-10-22T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-advanix-biliary-stents-bags-fda-ce-mark-clearances_221010/ 2010-10-22T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-turnover-falls-in-q3_221010/ 2010-10-22T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-gets-us-financial-support-for-york-syringe-manufacturing-facility_221010/ 2010-10-22T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/sport-endurance-commences-new-weight-loss-liquid-gel-cap-development_221010/ 2010-10-22T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-dna-vaccine-delivery-device-features-in-journal-gene-therapy_251010/ 2010-10-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-lucentis-receives-eu-approval_251010/ 2010-10-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shrink-nanotechnologies-signs-agreement-for-screening-software-production_251010/ 2010-10-24T19:28:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-wins-ce-mark-for-wallflex-biliary-rx-fully-covered-stent_251010/ 2010-10-24T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-to-viropharma-for-cinryze-manufacturing-expansion-activities_251010/ 2010-10-24T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/warner-chilcott-oral-contraceptive-lo-loestrin-fe-receives-fda-approval_251010/ 2010-10-25T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-lorcaserin-nda-gets-complete-response-letter-eisai_251010/ 2010-10-25T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/standard-homeopathic-to-voluntarily-recall-hylands-teething-tablets_251010/ 2010-10-25T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-fluenz-influenza-vaccine-maa-gets-chmp-positive-opinion_251010/ 2010-10-25T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/corepharma-signs-agreement-with-gsk-to-acquire-dexedrine-us-ndas_251010/ 2010-10-25T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-fluad-phase-iii-study-meets-primary-endpoint_251010/ 2010-10-25T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-pharma-to-bbb-to-co-develop-stroke-therapies_251010/ 2010-10-25T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-q2-fy11-revenues-increase_251010/ 2010-10-25T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-menveo-phase-iii-trial-shows-immunogenicity-in-infants_251010/ 2010-10-25T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/santhera-pharma-gets-us-canadian-rights-for-fipamezole-from-biovail_251010/ 2010-10-25T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/beijing-cdc-chooses-sinovac-biotech-to-supply-anflu_251010/ 2010-10-25T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-gets-drug-registration-certificate-for-anflu-in-hong-kong_251010/ 2010-10-25T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-rems-for-nuvigil-provigil-get-fda-approval_251010/ 2010-10-25T04:46:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/omeros-gets-grants-from-vulcan-capital-lsdf-for-gpcr-program_251010/ 2010-10-25T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/amt-gene-therapy-product-reduces-cholesterol-levels_251010/ 2010-10-25T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/medtronic-introduces-captivia-delivery-system-in-canada_251010/ 2010-10-25T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/revance-releases-two-rt001-phase-2b-trials-results/ 2010-10-25T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/global-health-ventures-concludes-x-excite-stability-test-_261010/ 2010-10-25T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-begins-azd9773-phase-iib-study_261010/ 2010-10-25T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/inviragen-pecet-commence-denvax-phase-1-trial-in-colombia_261010/ 2010-10-25T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-offers-glassia-in-us_261010/ 2010-10-26T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-to-momenta-pharma-for-enoxaparin-processing_261010/ 2010-10-26T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/rockland-immunochemicals-gets-phase-i-sbir-grant_261010/ 2010-10-26T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-signs-agreements-with-cipla-vitabiotics_261010/ 2010-10-26T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/healthstream-q3-revenues-up-18_261010/ 2010-10-26T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-commences-teriflunomide-phase-iii-teracles-study-_261010/ 2010-10-26T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-rebif-meets-primary-endpoint-in-phase-iii-reflex-1-study_261010/ 2010-10-26T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/celtic-therapeutics-resolvyx-pharma-ink-option-agreement-for-rx-10045_261010/ 2010-10-26T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-initiates-ofatumumab-phase-iii-study_261010/ 2010-10-26T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-q3-revenue-remains-unchanged_261010/ 2010-10-26T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-pharma-takes-over-three-rivers-pharma_261010/ 2010-10-26T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/trius-gets-torezolid-phosphate-patent-from-uspto_261010/ 2010-10-26T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ligocyte-pharma-presents-norovirus-vaccine-phase-iii-challenge-study-results_261010/ 2010-10-26T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/idc-signs-license-development-agreement-with-medimmune_261010/ 2010-10-26T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/supergen-q3-revenues-up_261010/ 2010-10-26T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/hcri-expands-dual-antiplatelet-therapy-study-into-australia-new-zealand_261010/ 2010-10-26T05:32:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/boehringer-ingelheim-macrogenics-form-global-alliance_261010/ 2010-10-26T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-partners-hiht-university-to-create-large-investigator-site-in-northern-india_261010/ 2010-10-26T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-to-step-up-generic-drug-line-in-india_261010/ 2010-10-26T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-sees-slight-increase-in-q2-revenue_271010/ 2010-10-26T21:18:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxo-agrees-to-pay-750m-for-manufacturing-lapses_271010/ 2010-10-27T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/chugai-submits-application-for-additional-indication-of-pegasys-copegus_271010/ 2010-10-27T00:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/millennium-in-research-pact-with-therasis_271010/ 2010-10-27T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-q3-revenues-up-5_271010/ 2010-10-27T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-net-sales-rise-marginally-in-q3_271010/ 2010-10-27T01:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/a5-labs-institute-of-microbiology-partner-for-interferon-products-production_271010/ 2010-10-27T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/novotech-deploys-oracle-siebel-clinical-trial-management-system_271010/ 2010-10-27T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/strativa-pharma-sobi-ink-agreement-for-nascobal-nasal-spray_271010/ 2010-10-27T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-chooses-nutritional-alliance-to-distribute-nyloxin_271010/ 2010-10-27T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/wcg-acquires-icon-roselle-optinor_271010/ 2010-10-27T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/hebei-aoxing-passes-chinese-gmp-inspection-aoxing-pharma_271010/ 2010-10-27T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmavigilant-upgrades-inspire-edc-system-to-support-multiple-languages_271010/ 2010-10-27T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-prolia-gets-final-recommendation-form-nice_271010/ 2010-10-27T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-gets-japanese-marketing-approval-for-treakisym-_271010/ 2010-10-27T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-net-revenues-increase-in-q3_271010/ 2010-10-27T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-q3-revenues-down-marginally_271010/ 2010-10-27T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/verona-pharma-starts-trail-for-chronic-cough_271010/ 2010-10-27T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-pharma-introduces-hyperuricemia-drug-in-canada_271010/ 2010-10-27T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/celtic-therapeutics-resolvyx-pharmaceuticals-form-ophthalmology-partnership_271010/ 2010-10-27T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/miragen-university-of-colorado-sign-microrna-therapeutics-agreements_271010/ 2010-10-27T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-virtualscopics-enter-into-strategic-alliance_271010/ 2010-10-27T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-revenues-up-73-in-q3-_271010/ 2010-10-27T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicell-q3-revenues-increase_281010/ 2010-10-27T21:08:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-vesicare-od-gets-japanese-approval_281010/ 2010-10-27T23:07:00+00:00 https://www.pharmaceutical-business-review.com/news/sangamo-biosciences-q3-revenues-fall_281010/ 2010-10-27T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/laureate-aveo-in-antibody-therapeutic-development-manufacturing-pact_281010/ 2010-10-28T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/arbor-pharma-names-new-vp-of-medical-affairs_281010/ 2010-10-28T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-edge-nutrition-names-new-senior-vice-president_281010/ 2010-10-28T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-q3-revenues-surge_281010/ 2010-10-28T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/mhlw-clears-abbott-japan-eisai-humira-pre-filled-syringe-for-ra_281010/ 2010-10-28T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/b-braun-recalls-seven-lots-of-heparin-injection-products_281010/ 2010-10-28T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-jingxin-pharma-sign-insomnia-drug-license-collaboration-agreement_281010/ 2010-10-28T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/hgs-revenues-rise-in-q3_281010/ 2010-10-28T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-discontinue-antiobesity-drug-development_281010/ 2010-10-28T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-gets-eur37m-grant-for-cystic-fibrosis-drug-discovery_281010/ 2010-10-28T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-invest-600m-for-global-research-headquarters-expansion_281010/ 2010-10-28T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/sfda-approves-lotus-pharma-asthama-drug-clinical-trial_281010/ 2010-10-28T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-stroke-prevention-drug-pradax-gets-health-canada-approval_281010/ 2010-10-28T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-india-executes-sildenafil-citrate-bulk-purchase-order-in-west-africa-281010/ 2010-10-28T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-gets-japanese-approval-for-cravit-intravenous-injections_281010/ 2010-10-28T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-starts-methotrexate-injection-voluntary-recall-in-us_281010/ 2010-10-28T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-initiates-human-cl-rhfviii-phase-2-trial_281010/ 2010-10-28T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-revenues-fall-in-q3_281010/ 2010-10-28T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/avacta-gets-order-for-optim-1000-system_271010/ 2010-10-28T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/verona-pharma-initiates-vrp700-clinical-trial_271010/ 2010-10-28T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-nutrition-introduces-new-line-of-cookie-dough-nutrition-bars_281010/ 2010-10-28T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/vangent-receives-pmits-contract-from-military-health-system_291010/ 2010-10-28T19:45:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-acquires-trubion-pharma_291010/ 2010-10-29T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-pharma-latuda-gets-fda-nod_291010/ 2010-10-29T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-q3-net-revenues-fall_291010/ 2010-10-29T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/stirling-names-new-chief-financial-officer_291010/ 2010-10-29T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharma-to-take-over-theramex-from-merck-serono-_291010/ 2010-10-29T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-files-patent-infringement-lawsuit-against-nycomed_291010/ 2010-10-29T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/amira-pharma-commences-am152-phase-1-study-_291010/ 2010-10-29T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-q3-revenues-rise_291010/ 2010-10-29T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/idenix-pharma-names-new-ceo_291010/ 2010-10-29T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ancora-pharma-strengthens-scientific-advisory-board_291010/ 2010-10-29T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/bemis-net-sales-rise-in-q3_291010/ 2010-10-29T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-adds-6-new-asthma-respiratory-generic-drugs-in-india_291010/ 2010-10-29T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/lubrizol-q3-revenues-increase_291010/ 2010-10-29T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-pharma-to-acquire-baxter-healthcare-multi-source-injectables-business_291010/ 2010-10-29T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mhlw-clears-abbott-japan-eisai-humira-pre-filled-syringe-for-crohns-disease-ankylosing-spondylitis_291010/ 2010-10-29T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-bristol-myers-squibb-chronic-myeloid-leukemia-drug-sprycel_291010/ 2010-10-29T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-to-acquire-bmp-sunstone-in-china_291010/ 2010-10-29T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-to-vivus-qnexa-nda_291010/ 2010-10-29T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-files-degarelix-acetate-maa-to-mhlw-_291010/ 2010-10-29T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-almirall-release-accord-copd-ii-phase-iii-trial-results_291010/ 2010-10-29T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/adesso-solutions-novartis-ink-multi-year-saas-contract_011110/ 2010-10-31T18:12:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-unveils-cobas-e-602-modular-analyzer-in-us-011011/ 2010-10-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-enters-into-agreement-for-optimizer-technology_011110/ 2010-10-31T19:19:00+00:00 https://www.pharmaceutical-business-review.com/news/taro-pharma-net-sales-rise-10_011110/ 2010-10-31T22:15:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-sankyo-sign-nexium-co-promotion-agreement_011110/ 2010-10-31T22:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-app-pharma-metoprolol-tartrate-injection-usp_011110/ 2010-10-31T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-revolade-xyzal-get-japanese-approval_011110/ 2010-10-31T23:12:00+00:00 https://www.pharmaceutical-business-review.com/news/global-specialty-enzymes-market-poised-to-reach-43bn-by-2015-global-industry-analysts_011110/ 2010-10-31T23:19:00+00:00 https://www.pharmaceutical-business-review.com/news/idenix-pharma-revenues-increase-in-q3_011110/ 2010-11-01T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-pharma-nuedexta-gets-fda-approval_011110/ 2010-11-01T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/neuraxon-releases-nxn-188-phase-2-trial-results_011110/ 2010-11-01T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-presents-hepatitis-c-compounds-phase-iia-trial-results_011110/ 2010-11-01T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-revenues-up-154-in-fiscal-2010_011110/ 2010-11-01T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/bausch-lomb-designates-new-vp-president_011110/ 2010-11-01T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-submits-pixuvri-maa-to-ema_011110/ 2010-11-01T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-teflaro-gets-fda-nod_011110/ 2010-11-01T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/labtec-starts-sufentanil-transdermal-patch-phase-ii-trial_011110/ 2010-11-01T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-names-new-r-d-projects-vice-president_011110/ 2010-11-01T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/dyadem-opens-second-office-in-europe_011110/ 2010-11-01T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/caraco-pharma-q2-net-sales-rise_011110/ 2010-11-01T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-mabthera-gets-ec-approval-_011110/ 2010-11-01T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-novartis-brain-tumor-drug-afinitor_011110/ 2010-11-01T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-amicus-in-fabry-disease-drug-amigal-development-pact_011110/ 2010-11-01T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-biodel-linjeta-nda-_011110/ 2010-11-01T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/balchem-appoints-two-new-directors_031110/ 2010-11-01T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-sees-surge-in-q3-revenue_011110/ 2010-11-01T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-pharma-q3-revenues-soar_011110/ 2010-11-01T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pays-50m-to-incyte-under-incb18424-license-agreement_021110/ 2010-11-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-technologies-receives-grants-under-ppaca-program_021110/ 2010-11-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/act-health-management-services-selects-nextgen-ambulatory-ehr-practice-management_021110/ 2010-11-01T20:16:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-revenues-surge-in-q3_021110/ 2010-11-01T21:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/valeant-kadmon-pharma-sign-strategic-agreements_021110/ 2010-11-01T21:50:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-q3-revenues-up_021110/ 2010-11-01T21:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ldm-group-appoints-new-channel-development-vice-president_021110/ 2010-11-01T22:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-medtronic-talent-captivia-delivery-system_021110/ 2010-11-01T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-make-pradaxa-available-in-us_021110/ 2010-11-02T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-pharma-gets-grant-for-vgx-3100-phase-ii-trial_021110/ 2010-11-02T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-revenues-rise-in-q3_021110/ 2010-11-02T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/bioscrip-promotes-coo-to-ceo_021110/ 2010-11-02T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/nycomed-acquires-guangdong-techpool-bio-pharma-in-china_021110/ 2010-11-02T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pays-25m-milestone-payment-to-depomed_021110/ 2010-11-02T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/x-body-biosciences-gets-drug-research-grant_021110/ 2010-11-02T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-q3-sales-up-20_021110/ 2010-11-02T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-q3-revenue-rises-39_021110/ 2010-11-02T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-to-open-diabetes-research-center-in-china_021110/ 2010-11-02T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-sees-revenue-fall-in-q3_021110/ 2010-11-02T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-dako-form-alliance-for-co-development-of-targeted-therapies_021110/ 2010-11-02T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/chelsea-reports-net-loss-in-q3_021110/ 2010-11-02T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-releases-interim-taliglucerase-alfa-switchover-trial-results_021110/ 2010-11-02T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/pro-pharma-to-get-federal-grants-under-qtdp-program_021110/ 2010-11-02T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-appoints-new-vp-business-development-head-of-commercial-operations_021110/ 2010-11-02T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ingenuity-systems-geospiza-partner-for-sequencing-workflow_031110/ 2010-11-03T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/omjpi-watson-laboratories-sign-supply-distribution-agreement_031110/ 2010-11-03T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-laboratories-revenues-surge-in-q3_031110/ 2010-11-03T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/somaxon-pharma-gets-silenor-development-grant_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-pharma-gets-five-therapeutic-discovery-project-grants_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lupin-pharma-desloratadine-tablets-5mg_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-presents-onbrez-breezhaler-phase-iii-study-results_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-pharma-reports-fall-in-q3-revenue_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-bristol-myers-ipilimumab-bla-review-timeline_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/dongbao-selects-sobi-as-iron-sucrose-rechon-distribution-partner-in-europe_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/qlt-q3-revenues-fall-23_031110/ 2010-11-03T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/cenerx-biopharma-tririma-shows-good-safety-profile-in-study_031110/ 2010-11-03T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cambrex-acquires-51-stake-in-zenara-pharma_031110/ 2010-11-03T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/enzon-pharma-q3-revenues-up_031110/ 2010-11-03T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/gtx-gets-12m-grant_031110/ 2010-11-03T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/talecris-rolls-out-prolastin-c-in-canada_031110/ 2010-11-03T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/hepalife-to-develop-transdermal-pain-patch_031110/ 2010-11-03T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/nmt-expands-focus-to-drive-market-growth_031110/ 2010-11-03T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-idev-supera-veritas-delivery-system_031110/ 2010-11-03T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/d-pharm-selects-cro-for-dp-b99-clinical-development-in-china_031110/ 2010-11-03T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-simcere-pharma-to-jointly-co-develop-bms-817378_031110/ 2010-11-03T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-gets-two-grants-to-support-drug-delivery-technologies_031110/ 2010-11-03T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-pharma-gets-grants-for-five-projects_031110/ 2010-11-03T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/idaho-seeks-fda-clearance-for-filmarray-respiratory-panel-041110/ 2010-11-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-sees-23-fall-in-q3-net-sales_041110/ 2010-11-03T22:18:00+00:00 https://www.pharmaceutical-business-review.com/news/caliper-sony-dadc-to-co-develop-plastic-consumables-for-microfluidics-products_041110/ 2010-11-03T22:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-cardiokine-terminate-lixivaptan-collaboration_041110/ 2010-11-03T22:34:00+00:00 https://www.pharmaceutical-business-review.com/news/adventrx-files-exelbine-nda_041110/ 2010-11-03T22:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nejm-publishes-novartis-afinitor-phase-iii-study-results_041110/ 2010-11-04T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/hybrigenics-files-patent-application-for-inecalcitol-soft-gelatin-capsules_041110/ 2010-11-04T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-sales-grow-21-in-q1_041110/ 2010-11-04T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-pharma-gets-irs-qtdp-grant_041110/ 2010-11-04T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/lipocine-obtains-grants-under-qtdp-program_041110/ 2010-11-04T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-receives-qtdp-grant-for-hematide-development-_041110/ 2010-11-04T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-names-new-ceo_041110/ 2010-11-04T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharma-sees-fall-in-q3-revenues_041110/ 2010-11-04T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-takeda-initiate-tak-700-phase-iii-trial-_041110/ 2010-11-04T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-newron-release-safinamide-study-results_041110/ 2010-11-04T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/huber-gets-api-production-approval_031110/ 2010-11-04T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/derma-sciences-obtains-rd-grant-from-us-government_041110/ 2010-11-04T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-pharma-medtronic-chdi-team-up-to-advance-aln-htt-_041110/ 2010-11-04T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-presents-new-data-on-4cmenb-candidate-_041110/ 2010-11-04T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/durect-q3-revenues-marginally-fall_041110/ 2010-11-04T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/abd-serotec-signs-agreement-with-institute-of-cancer-research_041110/ 2010-11-04T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/antigenics-gets-grants-under-qtdp-program-_041110/ 2010-11-04T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/achillion-gets-2m-grant-for-hcv-clinical-candidates-development_041110/ 2010-11-04T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-avp-21d9-emergent-biosolutions/ 2010-11-04T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/trt-receives-notification-of-grant-for-softwave-technology-development_051110/ 2010-11-04T19:42:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-cymbalta-gets-fda-approval_051110/ 2010-11-04T21:41:00+00:00 https://www.pharmaceutical-business-review.com/news/sirona-biochem-receives-nrc-irap-funding-for-sglt2-inhibitors-development_051110/ 2010-11-04T21:47:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-presents-rg7204-phase-ii-trial-results_051110/ 2010-11-04T21:52:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-sees-33-rise-in-q3-revenues_051110/ 2010-11-04T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-pharma-revenues-down-in-q3_051110/ 2010-11-04T22:59:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-q3-revenues-up_051110/ 2010-11-04T23:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-pharma-gets-milestone-payment-under-nitromist-pact-_051110/ 2010-11-04T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/microdose-therapeutx-gets-therapeutic-four-discovery-project-grants_051110/ 2010-11-04T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/biovest-to-get-irs-grant-for-biovaxid-development_051110/ 2010-11-05T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/bitop-initiates-ectoin-inhalation-solution-trial_051110/ 2010-11-05T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ricerca-biosciences-names-new-senior-director-of-drug-safety_051110/ 2010-11-05T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/senesco-gets-sns01-t-development-grants-_051110/ 2010-11-05T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/targacept-net-operating-revenues-rise-marginally-in-q3_051110/ 2010-11-05T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrition-21-provita-sign-licensing-agreement-for-coldizin_051110/ 2010-11-05T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/epo-issues-patent-for-genesis-biopharma-anti-cd55-targeted-cancer-therapy_051110/ 2010-11-05T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/integenx-rolls-out-apollo-324-system_081110/ 2010-11-07T19:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-bms-kombiglyze-xr-gets-fda-nod_081110/ 2010-11-07T22:24:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-inks-lodotra-commercialisation-agreement-with-mundipharma_081110/ 2010-11-07T22:29:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-presents-actemra-rose-trial-data_081110/ 2010-11-07T22:59:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-mycofenolatmofetil-actavis-in-europe_081110/ 2010-11-07T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/nordion-capgemini-extend-information-technology-services-agreement_081110/ 2010-11-07T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-releases-pv-10-phase-2-study-data_081110/ 2010-11-07T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/hcl-technologies-to-deploy-oracle-siebel-ctms-in-novotech_081110/ 2010-11-07T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/clinical-data-gets-rd-grants-for-vilazodone-stedivaze_081110/ 2010-11-08T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-xenoport-update-on-horizant-review_081110/ 2010-11-08T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/celanese-introduces-vitaldose-polymer-based-excipient-for-pharma-industry_081110/ 2010-11-08T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/american-regent-voluntary-recalls-magnesium-sulfate-injection_081110/ 2010-11-08T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-pharma-discusses-with-tga-for-pv-10-approval_081110/ 2010-11-08T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/aceto-sees-241-rise-in-q1-net-sales_081110/ 2010-11-08T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-receives-grant-under-qtpd-program_081110/ 2010-11-08T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-introduce-crystal-veil-cool_081110/ 2010-11-08T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/neuraltus-pharma-receives-np001-np002-np003-development-grants_081110/ 2010-11-08T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/edimer-pharma-presents-xlhed-study-results_081110/ 2010-11-08T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-q3-revenue-up_081110/ 2010-11-08T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pharmatech-suzhou-toxicology-facility-gets-sfda-glp-certificate_081110/ 2010-11-08T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/envivo-pharma-presents-evp-6124-research-results_081110/ 2010-11-08T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-q3-revenue-nosedives_081110/ 2010-11-08T03:32:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/santarus-second-budesonide-mmx-phase-iii-clinical-study-meets-primary-endpoint_081110/ 2010-11-08T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/glg-pharma-gets-qtdp-grant-for-cancer-therapeutics-development_081110/ 2010-11-08T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/hutchison-medipharma-gets-125m-support-from-mitsui_081110/ 2010-11-08T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/medlink-acquires-medappz_091110/ 2010-11-08T17:46:00+00:00 https://www.pharmaceutical-business-review.com/news/xdx-allomap-meets-all-ctaftechnology-assessment-criteria-101109/ 2010-11-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bdi-pharma-introduces-connect_091110/ 2010-11-08T18:32:00+00:00 https://www.pharmaceutical-business-review.com/news/kendle-q3-revenues-fall_091110/ 2010-11-08T22:31:00+00:00 https://www.pharmaceutical-business-review.com/news/kane-biotech-dispersinb-passes-fda-critical-sensitisation-test_091110/ 2010-11-08T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/mystic-pharmaceuticals-gets-qtdp-grant-for-versidoser-delivery-platform_091110/ 2010-11-08T22:57:00+00:00 https://www.pharmaceutical-business-review.com/news/musclepharm-in-research-pact-with-university-of-oklahoma_091110/ 2010-11-08T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sdix-sees-rise-in-q3-revenues_091110/ 2010-11-08T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-authorises-athersys-to-initiate-multistem-phase-ii-trial_091110/ 2010-11-08T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/antisoma-gets-qtdp-grant-for-as1413-development_091110/ 2010-11-08T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-collaborates-with-university-of-british-columbia-for-listeria-vaccines-development_091110/ 2010-11-08T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-oncology-names-new-senior-vice-president-of-clinical-operations_091110/ 2010-11-08T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/aqua-pharma-names-new-product-development-executive-director_091110/ 2010-11-08T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-pharma-appoints-new-chief-medical-officer-vp-of-product-development-medical-affairs_091110/ 2010-11-08T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-releases-dabigatran-etexilate-assessing-re-ly-trial-results_091110/ 2010-11-09T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/diamedica-signs-research-collaboration-with-the-sanford-project_091110/ 2010-11-09T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-elimiates-need-for-advisory-committee-meeting-for-endo-pharma-oxymorphone_091110/ 2010-11-09T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-presents-results-on-cel-2000-depovax-delivery-platform_091110/ 2010-11-09T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-gets-244m-grant-for-cancer-programs_091110/ 2010-11-09T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/tb-alliance-introduces-first-clinical-trial-of-a-novel-tb-drug-regimen_091110/ 2010-11-09T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/aqua-pharma-appoints-new-vice-president-of-corporate-development_091110/ 2010-11-09T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-eligible-for-milestone-payment-from-pfizer_091110/ 2010-11-09T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/orvacs-begins-eramune-01-phase-ii-study_091110/ 2010-11-09T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrition-21-gets-funding-for-insulin-technology-development_091110/ 2010-11-09T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/oncogenex-pharma-names-new-cfo_091110/ 2010-11-09T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/novabay-pharma-wins-grant-to-treat-impetigo_091110/ 2010-11-09T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-q3-revenues-down_091110/ 2010-11-09T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/medidata-solutions-q3-revenues-up-17_101110/ 2010-11-09T18:33:00+00:00 https://www.pharmaceutical-business-review.com/news/a5-labs-cro-validates-laboratory-information-management-system_101110/ 2010-11-09T18:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biosof-wins-qtdp-grant-for-pubseq_101110/ 2010-11-09T18:38:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-reports-marginal-rise-in-q3-revenues_101110/ 2010-11-09T22:33:00+00:00 https://www.pharmaceutical-business-review.com/news/eusa-pharma-submits-erwinase-bla_10110/ 2010-11-09T22:34:00+00:00 https://www.pharmaceutical-business-review.com/news/snowdon-obtains-three-year-contract-from-department-of-defense_101110/ 2010-11-09T22:37:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-rx-gets-us-patent-for-pharmaceutical-films-manufacturing_101110/ 2010-11-09T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/acadia-pharma-gets-michael-j-fox-foundation-grant-for-parkinsons-drug-development_101110/ 2010-11-09T22:47:00+00:00 https://www.pharmaceutical-business-review.com/news/opexa-therapeutics-reports-net-loss-in-q3_101110/ 2010-11-09T22:55:00+00:00 https://www.pharmaceutical-business-review.com/news/in-cell-art-merial-ink-research-collaboration-agreement_101110/ 2010-11-09T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/biovista-signs-research-collaboration-agreement-with-pfizer_101110/ 2010-11-09T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/scynexis-earns-milestone-payment-under-merial-collaboration_101110/ 2010-11-09T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/phytomedics-gets-grant-for-ra-drug-development_101110/ 2010-11-09T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/immunologix-genscript-form-human-antibody-therapeutics-partnership_101110/ 2010-11-10T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/vyteris-gets-qtdp-grant-to-advance-smart-patch-technology_101110/ 2010-11-10T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pharmatech-sees-20-rise-in-q3-net-revenues_101110/ 2010-11-10T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-immunomedics-release-epratuzumab-emblem-study-results_101110/ 2010-11-10T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/nabi-concludes-patient-recruitment-in-nicvax-second-phase-iii-trial_101110/ 2010-11-10T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/flexible-stenting-solutions-reveals-flexstent-system-clinical-results_101110/ 2010-11-10T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/american-oriental-bioengineering-q3-revenues-up-161_101110/ 2010-11-10T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-receives-approval-to-initiate-bi-204-phase-ii-trial_101110/ 2010-11-10T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/protein-sciences-umn-pharma-expand-license-agreement_101110/ 2010-11-10T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bmp-sunstone-sees-334-rise-in-q3-revenues_101110/ 2010-11-10T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/microdose-collaborates-with-nexus6_101110/ 2010-11-10T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/from-otc-products-to-brands_101110/ 2010-11-10T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-seek-regulatory-approval-for-smart-pill_111110/ 2010-11-10T18:28:00+00:00 https://www.pharmaceutical-business-review.com/news/integenx-gets-qtdp-grants_111110/ 2010-11-10T19:47:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-research-gets-topical-transdermal-formulations-research-grants_111110/ 2010-11-10T22:09:00+00:00 https://www.pharmaceutical-business-review.com/news/supergen-halts-sgi-1776-phase-1-trial_111110/ 2010-11-10T22:11:00+00:00 https://www.pharmaceutical-business-review.com/news/prophase-sees-fall-in-q3-sales_111110/ 2010-11-10T22:14:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-research-quotient-clinical-partner-to-advance-new-medicines_111110/ 2010-11-10T22:20:00+00:00 https://www.pharmaceutical-business-review.com/news/china-medicine-q3-revenues-down-84_111110/ 2010-11-10T22:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cyanotech-appoints-new-president-ceo-director_111110/ 2010-11-10T22:26:00+00:00 https://www.pharmaceutical-business-review.com/news/wcc-promotes-chief-medical-officer-to-president_111110/ 2010-11-10T22:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bionovo-menerba_111110/ 2010-11-10T22:32:00+00:00 https://www.pharmaceutical-business-review.com/news/polymedix-gets-fda-clearence-for-pmx-30063-ind-application_111110/ 2010-11-10T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-receives-grants-for-ampligen-alferon-development_111110/ 2010-11-10T22:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-commences-bafetinib-pharmacokinetic-clinical-trial_111110/ 2010-11-10T22:48:00+00:00 https://www.pharmaceutical-business-review.com/news/antigen-express-gets-two-irs-therapeutic-discovery-project-grants_111110/ 2010-11-10T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/huifeng-partners-jucheng-for-diosmin-production-plant_111110/ 2010-11-10T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/federal-prosecutors-indict-former-gsk-vice-president-with-obstruction-of-probe_111110/ 2010-11-11T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/nycomed-us-names-new-senior-vice-president-general-counsel_111110/ 2010-11-11T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-reveals-lorcaserin-bloom-dm-phase-3-trial-results_111110/ 2010-11-11T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/surmodics-sees-16-fall-in-q4-revenues_111110/ 2010-11-11T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-to-adolor-analgesic-compound_111110/ 2010-11-11T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-egrifta-gets-fda-nod_111110/ 2010-11-11T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-q3-revenue-climbs-89_111110/ 2010-11-11T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/kylin-therapeutics-gets-prnai-nanoparticle-cancer-treatment-research-grant_111110/ 2010-11-11T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/scolr-pharma-q3-revenues-drop-53_111110/ 2010-11-11T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/nutri-health-offers-new-vitamin-d3-supplement-with-added-prebiotics_111110/ 2010-11-11T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/main-street-family-pharmacy-injectics-sign-marketing-agreement_111110/ 2010-11-11T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/medquist-sees-34-increase-in-q3-revenue_121110/ 2010-11-11T18:24:00+00:00 https://www.pharmaceutical-business-review.com/news/applied-precision-installs-deltavision-omx-imaging-systems-121110/ 2010-11-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-labs-janssen-collaborate-to-distribute-bystolic-savella-in-canada_121110/ 2010-11-11T22:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/laureate-pharma-establishes-regulatory-affairs-group_121110/ 2010-11-11T22:25:00+00:00 https://www.pharmaceutical-business-review.com/news/centocor-ortho-biotech-submits-simponi-sbla_121110/ 2010-11-11T22:33:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-fresenius-kabi-partner-for-hesylated-pharmaceuticals-production_121110/ 2010-11-11T22:45:00+00:00 https://www.pharmaceutical-business-review.com/news/lotus-pharma-q3-revenue-rises-275_121110/ 2010-11-11T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/aobo-rolls-out-wujia-rongxue-oral-liquid_121110/ 2010-11-11T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-sage-bionetworks-ink-cns-disease-research-collaboration_121110/ 2010-11-11T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-halts-asa404-clinical-trial_121110/ 2010-11-11T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/syntiron-gets-grant-to-develop-vaccine-technology-platform_121110/ 2010-11-11T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-pharma-extends-oral-controlled-release-development-capabilities_121110/ 2010-11-11T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-sees-fall-in-q1-sales_121110/ 2010-11-12T00:15:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/acetylon-pharma-gets-two-therapeutic-discovery-project-grants_121110/ 2010-11-12T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/oligomerix-gets-sbir-phase-ii-grant-to-discover-alzheimers-drugs_121110/ 2010-11-12T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-vtu-technology-sign-technology-marketing-collaboration-agreement_121110/ 2010-11-12T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/comp-issues-positive-opinion-on-celsion-thermodox-odd-application_121110/ 2010-11-12T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/echo-files-with-fda-for-prelude-skinprep-system-4-lidocaine-cream-approval_121110/ 2010-11-12T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-to-get-eur3m-milestone-payments-from-boehringer-ingelheim_121110/ 2010-11-12T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-takes-over-norgine-otc-products_121110/ 2010-11-12T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-fiocruz-extend-tropical-disease-collaboration_151110/ 2010-11-14T22:12:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-appoints-new-president-chief-operating-officer_151110/ 2010-11-14T22:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bohai-pharma-sees-22-rise-in-q1-revenues_151110/ 2010-11-14T22:31:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-pharma-reports-113m-net-loss-in-q3_151110/ 2010-11-14T22:57:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-pharma-names-new-cfo_151110/ 2010-11-14T23:17:00+00:00 https://www.pharmaceutical-business-review.com/news/eyetech-gets-qtdp-grant-for-macugen-formulation_151110/ 2010-11-14T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/scios-reveals-natrecor-ascend-hf-study-results_151110/ 2010-11-15T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-files-generic-oleptro-anda-_151110/ 2010-11-15T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/tca-cellular-therapy-receives-adult-stem-cell-therapies-development-grant_151110/ 2010-11-15T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrition-21-q1-revenues-fall_151110/ 2010-11-15T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ewpi-updates-on-ghana-generic-drug-manufacturing-facility_151110/ 2010-11-15T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/alpvision-to-unveil-cryptoglyph-technology-latest-version_151110/ 2010-11-15T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/cytomx-gets-two-grants-to-support-preclinical-programs_151110/ 2010-11-15T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/menicon-enters-into-agreement-with-optimed_151110/ 2010-11-15T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-releases-emphasis-hf-trial-results-evaluating-inspra_151110/ 2010-11-15T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/bausch-lomb-starts-bol-303259-x-phase-2b-study-nicox_151110/ 2010-11-15T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-offers-aryla-to-accelerate-antibody-optimisation_151110/ 2010-11-15T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pozen-to-receive-milestone-from-astrazeneca-for-vimovo_151110/ 2010-11-15T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/dalton-pharma-lonza-to-offer-contract-chemistry-services-manufacturing_151110/ 2010-11-15T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/icon-proteome-sciences-in-pact-to-offer-biomarker-solutions-to-pharma-companies_151110/ 2010-11-15T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/china-shenghuo-q3-sales-fall-19_151110/ 2010-11-15T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-introduces-cycloset-in-us-market_151110/ 2010-11-15T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-pharma-q3-revenues-nosedive_151110/ 2010-11-15T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/pro-pharma-q3-sales-decline_151110/ 2010-11-15T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/selexis-signs-agreement-with-zyngenia_151110/ 2010-11-15T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ap-pharma-q3-net-loss-widens_151110/ 2010-11-15T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/aryx-net-loss-narrows-in-q3_151110/ 2010-11-15T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/biowa-licenses-potelligent-technology-to-astellas-affiliate-agensys_151110/ 2010-11-15T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/london-genetics-astrimmune-to-tie-up-for-cancer-vaccine-development_151110/ 2010-11-15T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/itt-buys-oi-161110/ 2010-11-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chiltern-offers-safe-tmf-solution_161110/ 2010-11-15T19:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cielo-medsolutions-gets-sttr-grant_161110/ 2010-11-15T20:00:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-halaven-receives-fda-nod_161110/ 2010-11-15T23:00:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-for-vosaroxin-formulation-sunesis-pharma-_161110/ 2010-11-15T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/delrx-pharma-signs-loa-to-license-drug-delivery-system-to-therabiogen_161110/ 2010-11-15T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-rolls-out-gemcitabine-hcl-for-injection_161110/ 2010-11-15T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/3sbio-sees-249-rise-in-q3-revenues_161110/ 2010-11-15T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/vitabiotics-calls-back-six-food-supplements_151110/ 2010-11-15T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-releases-rivaroxaban-phase-iii-rocket-af-trial_161110/ 2010-11-16T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-completes-dcp-for-saizen-solution-for-injection-approval_161110/ 2010-11-16T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/amakem-gets-copd-drug-development-grant_161110/ 2010-11-16T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-offers-unitract-1ml-safety-syringes-in-us_161110/ 2010-11-16T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-gets-two-new-us-patents-_161110/ 2010-11-16T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/merrion-to-start-orazol-phase-iii-trial_161110/ 2010-11-16T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-biosciences-ed-therapy-vitaros-gets-health-canada-approval_161110/ 2010-11-16T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/elder-pharma-q2-net-sales-rise_161110/ 2010-11-16T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/interna-receives-innovation-credit-from-dutch-government_161110/ 2010-11-16T03:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mhra-approves-bafna-to-manufacture-amlodipine-_161110/ 2010-11-16T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-pharma-q3-sales-up-297_161110/ 2010-11-16T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/vectura-reveals-vr040-positive-result-in-parkinsons-trial_161110/ 2010-11-16T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/reneuron-treats-first-patient-in-ren001phase-i-trial-_161110/ 2010-11-16T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-pharma-commences-phase-1b-tivozanib-combination-trial-_161110/ 2010-11-16T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/orban-biotech-receives-qtdp-grant-for-insulin-b-chain-vaccine-_161110/ 2010-11-16T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/polymedix-umass-get-phase-2-sttr-grant_161110/ 2010-11-16T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/clinical-data-vilazodone-obtains-us-patent-_161110/ 2010-11-16T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/apc-in-pact-with-global-pharmaceutical-company_161110/ 2010-11-16T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/intelleflex-rolls-out-hmr-9090-handheld-reader-fmr-6000-fixed-reader_171110/ 2010-11-16T20:02:00+00:00 https://www.pharmaceutical-business-review.com/news/baxa-upgrades-doseedge-pharmacy-workflow-manager_171110/ 2010-11-16T21:12:00+00:00 https://www.pharmaceutical-business-review.com/news/aoxing-pharma-sees-20-rise-in-q1-sales_171110/ 2010-11-16T23:06:00+00:00 https://www.pharmaceutical-business-review.com/news/jdrf-amylin-ink-metreleptin-research-collaboration_171110/ 2010-11-16T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/abi-zydus-cadila-sign-maxisal-supply-agreement_171110/ 2010-11-16T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-forma-therapeutics-sign-drug-discovery-collaboration_171110/ 2010-11-16T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-allegra-d-60mg120mg-tablets-anda-gets-fda-approval_171110/ 2010-11-16T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ono-pharma-initiates-subcutaneous-methylnaltrexone-phase-2-trial-in-japan_171110/ 2010-11-17T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/jiangbo-pharma-q1-revenues-up-135_171110/ 2010-11-17T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-signs-agreement-with-kadrige_171110/ 2010-11-17T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/nautilus-neurosciences-tribute-pharma-sign-cambia-commercialisation-pact_171110/ 2010-11-17T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/lab-research-q3-revenues-up-31_171110/ 2010-11-17T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/arthritis-advisory-committee-recommends-fda-to-approve-hgsi-gsk-benlysta_171110/ 2010-11-17T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/novalix-takes-over-majority-stake-in-graffinity-pharma_171110/ 2010-11-17T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/china-ruitai-revenue-up-98-in-q3/ 2010-11-17T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-establishes-global-therapeutic-innovation-centers_171110/ 2010-11-17T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/us-district-court-confirms-lillys-alimta-patent-validity-_171110/ 2010-11-17T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharma-xenon-pharma-in-pact-to-develop-antisense-drugs-_171110/ 2010-11-17T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-pixuvri-pip-gets-european-approval_171110/ 2010-11-17T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-to-neogenix-16c3-antibody_171110/ 2010-11-17T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/china-biologic-q3-revenues-increases-332_171110/ 2010-11-17T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-q3-net-loss-shrinks_171110/ 2010-11-17T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-ipf-investigational-compound-bibf1120-shows-efficacy-in-phase-ii-study_171110/ 2010-11-17T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/effient-associated-with-low-mortality-rate-in-triton-timi-38-trial-lilly_171110/ 2010-11-17T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/yukon-medical-gets-qtdp-grant-for-smartmix-delivery-platform_171110/ 2010-11-17T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/anaptysbio-receives-qtdp-grants_171110/ 2010-11-17T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/the-urology-company-introduces-three-male-sexual-health-products_171110/ 2010-11-17T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/musclepharm-signs-fulfillment-agreement-with-ivitals_171110/ 2010-11-17T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/performrx-receives-pharmacy-benefit-management-contract-from-dgs_181110/ 2010-11-17T20:02:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-gardasil-gets-support-for-approval-from-fda-advisory-committee_181110/ 2010-11-17T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-pharma-lilly-release-byetta-retrospective-study-results_181110/ 2010-11-17T23:07:00+00:00 https://www.pharmaceutical-business-review.com/news/salvat-kwang-dong-sign-tarafenacin-development-agreement_181110/ 2010-11-17T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/phytopharm-initiates-cogane-phase-ii-trial_181110/ 2010-11-17T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/provid-fast-forward-extend-ms-drug-pv-267-development-partnership_181110/ 2010-11-17T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/medcac-panel-reviews-dendreon-provenge-impact_181110/ 2010-11-18T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/topaz-pharma-appoints-new-president-ceo_181110/ 2010-11-18T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-inks-sponsored-research-agreement-with-hokkaido-university_181110/ 2010-11-18T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/lubrizol-inaugurates-regional-applications-business-centre-in-mumbai_181110/ 2010-11-18T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/h-lundbeck-designates-new-president-of-us-subsidiary_181110/ 2010-11-18T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sci-plans-to-open-tablet-capsule-packaging-facility-_181110/ 2010-11-18T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-accepts-pixuvri-maa-cti_181110/ 2010-11-18T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-biopharma-gets-australian-patent-_181110/ 2010-11-18T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ista-pharma-bromday-gets-three-years-marketing-exclusivity-grant_181110/ 2010-11-18T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/bioniche-receives-4m-milestone-payment-from-endo-pharma_181110/ 2010-11-18T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-generic-tiazac-anda-gets-fda-nod_181110/ 2010-11-18T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-concludes-cladribine-tablets-phase-iii-trial-_181110/ 2010-11-18T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sun-pharma-generic-clarinex-tablets-5-mg_181110/ 2010-11-18T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-releases-positive-results-from-phase-2b-aspire-study_181110/ 2010-11-18T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/circassia-phase-ii-t-cell-vaccine-study-meets-safety-efficacy-endpoints_181110/ 2010-11-18T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-releases-phase-iii-define-study-results-_181110/ 2010-11-18T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/naurex-releases-glyx-13-trial-results_181110/ 2010-11-18T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-court-uphelds-two-kci-patents-validity_181110/ 2010-11-18T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-reveals-new-data-on-applications-of-rnai-technology_181110/ 2010-11-18T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-pharma-apex-pd-phase-iii-ipx066-study-met-primary-endpoint-_181110/ 2010-11-18T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/stromedix-in-licensing-pact-with-university-of-california_181110/ 2010-11-18T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/prism-pharma-gets-fda-approval-for-nexterone-_181110/ 2010-11-18T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-to-divest-diagnostics-business-to-sekisui-chemical-191110/ 2010-11-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/intercell-presents-v710-phase-ii-trial_191110/ 2010-11-18T22:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-pfizer-halt-apixaban-phase-3-appraise-2-trial_191110/ 2010-11-18T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-xgeva-receives-fda-approval_191110/ 2010-11-18T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/advanced-life-sciences-applies-orphan-drug-designation-for-als-886_191110/ 2010-11-18T22:59:00+00:00 https://www.pharmaceutical-business-review.com/news/agennix-q3-revenues-fall_191110/ 2010-11-18T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-in-co-development-licensing-pact-with-biozone-_191110/ 2010-11-18T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/forte-research-introduces-allegro-ctmssite-_191110/ 2010-11-19T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/inspiration-starts-treatment-in-phase-iii-obi-1-study_191110/ 2010-11-19T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-to-supply-bulk-drugs-to-pfizer-in-japan-korea_191110/ 2010-11-19T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-pharma-sta-9584-gets-dod-recommendation-for-1m-funding_191110/ 2010-11-19T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-unveils-aezs-108-study-results_191110/ 2010-11-19T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-updates-on-zybrestat-evaluating-falcon-trial_191110/ 2010-11-19T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-sells-oncolytic-virus-technology-development-rights-to-cold-genesys_181110/ 2010-11-19T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/synthon-tamsulosin-tablets-receive-european-clearance_191110/ 2010-11-19T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-unveils-dila2-based-delivery-platform-data_191110/ 2010-11-19T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/elorac-releases-cpo-solution-two-phase-iii-studies-results_191110/ 2010-11-19T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-takeda-recall-cancer-drug-velcade-in-europe-us-japan-malaysia_191110/ 2010-11-19T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-releases-new-darinaparsin-preclinical-data-_191110/ 2010-11-19T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ym-biosciences-extends-phase-iii-trial-for-jak-inhibitor-cyt387_191110/ 2010-11-19T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-3-axis-1032-trial-meets-primary-endpoint_191110/ 2010-11-19T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-introduces-advanced-vibex-auto-injectors_191110/ 2010-11-19T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pointcross-offers-sdis-technology-to-biopharma-industry_221110/ 2010-11-21T21:58:00+00:00 https://www.pharmaceutical-business-review.com/news/successehs-rolls-out-mobile-ehr-for-iphone_221110/ 2010-11-21T22:27:00+00:00 https://www.pharmaceutical-business-review.com/news/syndeohealth-ties-up-with-nargund_221110/ 2010-11-22T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/arch-biopartners-agrees-to-acquire-minority-stake-in-colorado-cancer-therapeutics_221110/ 2010-11-22T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-reveals-phase-ii-study-results_221110/ 2010-11-22T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/convergence-pharma-selcia-enter-into-drug-discovery-collaboration_221110/ 2010-11-22T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/f-star-in-drug-discovery-pact-with-boehringer-ingelheim_221110/ 2010-11-22T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prism-nexterone-premixed-injection-uses-cydex-captisol-technology-platform_221110/ 2010-11-22T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-puts-helix-topical-interferon-alpha-2b-phase-iiiii-ind-on-hold_221110/ 2010-11-22T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-zafirlukast-tablets-in-us_221110/ 2010-11-22T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/invega-sustenna-reduces-psychiatric-hospitalisation-rates-ortho-mcneil_221110/ 2010-11-22T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-pharma-bayer-two-phase-3-studies-of-vegf-trap-eye-meet-primary-endpoint_221110/ 2010-11-22T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-bio-reveals-nexact-technology-study-data_221110/ 2010-11-22T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/xanodyne-pharma-to-withdraw-darvon-darvocet-n-products_221110/ 2010-11-22T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-medical-to-present-sfp-phase-iib-study-data_221110/ 2010-11-22T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-unveils-orca-trial-results_221110/ 2010-11-22T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/bafna-pharma-gets-mhra-approval-to-manufacture-finasteride-_221110/ 2010-11-22T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-warns-against-vigor-25_221110/ 2010-11-22T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-agrees-to-extend-factor-viii-biopump-development-pact_221110/ 2010-11-22T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/immungene-gets-grant-for-anti-cancer-technology-development-_221110/ 2010-11-22T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-to-take-over-hemophilia-related-assets-of-archemix_221110/ 2010-11-22T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sbio-sb1317-enters-into-phase-1-trial_221110/ 2010-11-22T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-to-rexahn-pharma-_221110/ 2010-11-22T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/compugen-develops-discovery-platform-for-protein-family-members_221110/ 2010-11-22T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/grant-instruments-launches-ptr-35-360-rotator-231110/ 2010-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/myrexis-reports-azixa-anti-tumor-activity-in-phase-2-study_221110/ 2010-11-22T22:49:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharma-signs-zafirlukast-supply-distribution-agreement-with-astrazeneca_231110/ 2010-11-22T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-unveils-atrasentan-phase-2-study-results_231110/ 2010-11-22T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-laboratories-generic-cymbalta-gets-fda-nod_231110/ 2010-11-22T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/aoxing-pharma-jv-gets-manufacturing-license-from-sfda_231110/ 2010-11-22T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/grifols-rolls-out-flebogamma-10-dif-ivig-in-us_231110/ 2010-11-23T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-bio-files-protocol-for-proposed-prevonco-phase-3-trial_231110/ 2010-11-23T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-epo-grant-new-patents-tekmira-pharmaceuticals-_231110/ 2010-11-23T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/skyepharma-executes-patient-recruitment-in-flutiform-phase-iii-trials-_231110/ 2010-11-23T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-merck-to-jointly-develop-pre-clinical-neurology-drugs_231110/ 2010-11-23T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/profil-institute-extends-cardiometabolic-capabilities-for-diabetes-obesity-clinical-drug-trials-_231110/ 2010-11-23T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-pharma-commences-bal30072-phase-1-trial_231110/ 2010-11-23T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/omthera-pharma-reaches-agreement-with-fda-on-epanova-spa_231110/ 2010-11-23T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/a5-labs-submits-el-application-to-health-canada_231110/ 2010-11-23T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/winston-reveals-dolorac-nasal-solution-phase-ii-study-results_231110/ 2010-11-23T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/mimetogen-starts-mim-d3-assessing-phase-ii-trial_231110/ 2010-11-23T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-initiates-sativex-phase-iii-clinical-trials-_231110/ 2010-11-23T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-gets-favourable-ruling-in-paxil-product-liability-case_231110/ 2010-11-23T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/confidisc-introduces-us-patented-anti-illegal-drug-syringe_231110/ 2010-11-23T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-presents-cmx001-trial-results_231110/ 2010-11-23T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-publishes-ampligen-phase-iii-trial-results_231110/ 2010-11-23T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-initiates-welchol-patent-challenge_231110/ 2010-11-23T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/shangpharma-q3-revenue-rises-166-_231110/ 2010-11-23T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/neupro-improves-motor-sleep-non-motor-symptoms-of-pd-in-recover-study-ucb-_231110/ 2010-11-23T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bdsi-restarts-onsolis-manufacturing_231110/ 2010-11-23T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/nutraceutical-sees-rise-in-q4-sales_231110/ 2010-11-23T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-pharma-files-telaprevir-nda-to-fda_231110/ 2010-11-23T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/omni-bio-pharma-gets-new-us-patent-_231110/ 2010-11-23T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/united-drug-increases-use-of-pilgrim-smartsolve-solution_241110/ 2010-11-23T19:15:00+00:00 https://www.pharmaceutical-business-review.com/news/glencoe-software-open-microscopy-environment-consortium-release-updated-software-packages_241110/ 2010-11-23T21:34:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-files-truvada-tmc278-nda-_241110/ 2010-11-23T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-dr-reddys-sign-agreement-for-us-oral-penicillin-facility-products_241110/ 2010-11-23T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-gets-mjff-grant-for-acamprosate-prodrug-preclinical-study_241110/ 2010-11-23T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/idenix-to-receive-20m-milestone-payment-from-viiv-healthcare_241110/ 2010-11-23T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/standard-process-introduces-calamari-omega-3-liquid_241110/ 2010-11-24T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cns-gablofen-gets-fda-nod_241110/ 2010-11-24T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-acquires-patobios-gpcr-assay-technology_241110/ 2010-11-24T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/merrion-commences-drug-delivery-feasibility-option-agreement-with-rebel_241110/ 2010-11-24T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-updates-on-pv-10-compassionate-use-program_241110/ 2010-11-24T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/medical-futures-introduces-purfem-probiotic-in-canada-_241110/ 2010-11-24T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-acrux-get-fda-approval-for-axiron_241110/ 2010-11-24T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-prednisolone-ec-tablets_241110/ 2010-11-24T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-calls-back-paediatric-drugs-benadryl-tablets-motrin_241110/ 2010-11-24T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/achieve-clinical-research-commences-ibs-research-studies_241110/ 2010-11-24T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-terminates-hcv-deal-with-metabasis_241110/ 2010-11-24T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/precos-signs-service-agreement-with-janssen-pharma_241110/ 2010-11-24T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-supply-free-of-charge-lymphatic-filariasis-medicine-to-who_241110/ 2010-11-24T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/vivalis-gsk-get-fda-nod-for-influenza-vaccine-trial-with-eb66-technology_241110/ 2010-11-24T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/glycotex-gets-qtdp-grant-for-glyc-101-development-_241110/ 2010-11-24T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/highpoint-inks-strategic-partnership-with-nintex_251110/ 2010-11-24T21:29:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-launches-late-stage-customisation-suite_251110/ 2010-11-24T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/china-yongxin-pharma-q3-revenue-falls_241110/ 2010-11-24T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/biosyent-sees-14-rise-in-q3-sales_251110/ 2010-11-24T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-ends-allston-plant-operations_251110/ 2010-11-24T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nostrum-signs-licensing-agreement-with-imtech_251110/ 2010-11-24T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-generic-cymbalta-gets-tentative-fda-approval_251110/ 2010-11-24T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/genvec-partners-with-nmrc-to-develop-dengue-fever-vaccines-260111/ 2011-01-26T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/dtra-grants-cblb502-additional-research-fund-260111/ 2011-01-26T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/rapiscan-receives-eu-commission-licence-to-aid-in-cad-diagnosis-260111/ 2011-01-26T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-pharma-sees-152-rise-in-q4-sales-260111/ 2011-01-26T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/rpc-in-licensing-pact-with-university-of-florida-college-of-medicine-260111/ 2011-01-26T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-aln-ttr01-gets-comp-positive-opinion-for-orphan-drug-status-260111/ 2011-01-26T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-melanoma-cancer-vaccinebiosante-pharma-260111/ 2011-01-26T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-q4-revenues-fall-260111/ 2011-01-26T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-nuvigil-phase-iv-trial-shows-positive-result-260111/ 2011-01-26T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-to-file-maa-for-perampanel-in-us-eu-260111/ 2011-01-26T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-pharma-arthritis-drug-axorid-receives-license-extension-260111/ 2011-01-26T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dupont-develops-coverall-for-laboratory-pharmaceutical-markets-260111/ 2011-01-26T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-resolves-caduet-tablets-patent-dispute-with-pfizer-260111/ 2011-01-26T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/app-pharma-signs-commercialization-manufacturing-pact-with-teva-260111/ 2011-01-26T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/chemocentryx-starts-ccx832-phase-i-clinical-trial-260111/ 2011-01-26T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-starts-patient-recruitment-in-platinum-china-trial-260111/ 2011-01-26T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/simulations-plus-fda-form-research-agreement-260111/ 2011-01-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-signs-technology-licensing-pact-with-cu-270111/ 2011-01-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abaxis-signs-supply-agreement-with-bd-diagnostics-270111/ 2011-01-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/saic-grants-31m-sub-contract-to-pfenex-science-270111/ 2011-01-26T23:11:00+00:00 https://www.pharmaceutical-business-review.com/news/tianyin-pharma-completes-jiangchuan-macrolide-facility-construction-270111/ 2011-01-26T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmanet-anapharm-terminate-bioanalytical-services-pact-270111/ 2011-01-27T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/tryton-recruits-first-us-patient-for-coronary-stent-study-270111/ 2011-01-27T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/anadys-begins-dosing-in-hepatitis-drug-study-270111/ 2011-01-27T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-completes-api-manufacturing-facility-contruction-270111/ 2011-01-27T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/sinofresh-to-commence-homeopathic-antiseptic-nasal-spray-trial-270111/ 2011-01-27T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/inviragen-duke-nus-sign-mou-270111/ 2011-01-27T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/surmodics-q1-revenue-falls-270111/ 2011-01-27T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/qps-acquires-majority-stake-in-indian-cro-270111/ 2011-01-27T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/angiotech-receives-termination-notice-from-rex-270111/ 2011-01-27T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/innovation-pei-grants-fund-to-avrf-270111/ 2011-01-27T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ncpdp-introduces-rxreconn-280111/ 2011-01-27T20:32:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-berinert-gets-marketing-approval-in-israel-280111/ 2011-01-28T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/plexxikon-begins-arthritis-drug-study-280111/ 2011-01-28T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-breast-cancer-drug-fails-in-phase-iii-study-280111/ 2011-01-28T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-q2-revenues-up-280111/ 2011-01-28T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/tibotec-pharma-signs-manufacturing-pacts-280111/ 2011-01-28T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/microfluidics-renames-mrt-technology-applications-as-purenano-280111/ 2011-01-28T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-q4-revenue-rises-280111/ 2011-01-28T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-q4-net-sales-up-marginally-280111/ 2011-01-28T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-hydrocodone-bitartrate-acetaminophen-boca-pharmacal-280111/ 2011-01-28T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-pharma-concludes-patient-enrollment-in-phase-1-cancer-trial-280111/ 2011-01-28T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/medisafe-to-develop-product-to-reduce-pharma-counterfeiting-280111/ 2011-01-28T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/receptos-treats-first-patient-in-rpc1063-phase-1-trial-280111/ 2011-01-28T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-halts-dnage-funding-310111/ 2011-01-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-paladin-labs-digifab-280111/ 2011-01-30T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/mylam-pharma-nisoldipine-er-tablets-gets-fda-approval-310111/ 2011-01-30T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-depomed-phn-drug-310111/ 2011-01-30T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-lymphoma-drug-receives-fda-approval-for-maintenance-use-310111/ 2011-01-31T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-orion-to-develop-cancer-drugs-310111/ 2011-01-31T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-awards-eur33m-grant-to-aipgene-consortium-310111/ 2011-01-31T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-pays-milestone-to-morphosys-310111/ 2011-01-31T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-menveo-gets-fda-approval-for-use-in-2-to-10-years-of-age-310111/ 2011-01-31T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/oxygen-biotherapeutics-in-research-pact-with-hackensack-university-310111/ 2011-01-31T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-biomedica-sets-to-acquire-recipharmcobra-manufacturing-facility-310111/ 2011-01-31T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/antisoma-accede-trial-fails-to-meet-primary-endpoint-310111/ 2011-01-31T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-pharma-takes-over-taligen-therapeutics-310111/ 2011-01-31T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/chinese-government-grants-research-fund-to-bohai-pharma-310111/ 2011-01-31T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-zydus-to-strengthen-pharmaceutical-business-in-india-310111/ 2011-01-31T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-buys-assets-of-cell-targeting/ 2011-01-31T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/revolutions-medical-improves-prefilled-safety-syringe-technology-310111/ 2011-01-31T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-pharma-gattex-phase-3-study-met-primary-endpoint-310111/ 2011-01-31T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/caraco-pharma-q3-net-sales-down-310111/ 2011-01-31T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/alk-torii-pharma-sign-licensing-pact-310111/ 2011-01-31T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/caliper-trinean-enter-dropsense-platform-agreement-010211/ 2011-01-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-launches-early-probes-on-sanofi-takeda-drugs-010211/ 2011-01-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/research-finds-bristol-myers-squibbs-cancer-drug-capable-of-reducing-bowel-cancer-growth-010211/ 2011-01-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-q3-revenues-marginally-fall-010211/ 2011-01-31T20:43:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-biotech-submits-ppv-trial-application-with-sfda-010211/ 2011-01-31T21:29:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-pharma-concludes-patient-recruitment-in-bavituximab-phase-ib-trial/ 2011-01-31T21:58:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-pharma-introduces-pba-drug-in-us-010211/ 2011-01-31T22:34:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-appoints-new-president-and-ceo-010211/ 2011-02-01T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/maxygen-initiates-arthritis-drug-study-010211/ 2011-02-01T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/vbl-initiates-two-studies-of-cancer-drug-010211/ 2011-02-01T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharmaceuticals-to-take-over-swiss-otc-company-010211/ 2011-02-01T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-tentative-approval-for-famciclovir-tablets-aurobindo-pharma-010211/ 2011-02-01T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-q2-revenue-up-010211/ 2011-02-01T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/hutchison-medipharma-commences-fruquintinib-phase-i-trial-010211/ 2011-02-01T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/manhattan-pharma-continues-ast-915-development-010211/ 2011-02-01T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/imaginab-partners-with-eurogentec-010211/ 2011-02-01T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/specialty-injectable-drugs-to-grow-over-90bn-by-2014-greystone-research-010211/ 2011-02-01T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/breast-cancer-risk-declines-with-delayed-hrt-oxford-university-study-010211/ 2011-02-01T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/clinops-changes-name-to-emphusion-010211/ 2011-02-01T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cappella-starts-coronary-artery-stent-study-010211/ 2011-02-01T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-to-launch-nutritional-product-in-europe-010211/ 2011-02-01T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-to-supply-multiple-sclerosis-compound-for-nuron-010211/ 2011-02-01T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/circassia-shows-symptomatic-reduction-in-allergy-drug-trial/ 2011-02-01T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-acquires-curna-020211/ 2011-02-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmasmart-introduces-diagnostic-health-it-platform-020211/ 2011-02-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/frazier-takes-over-laboratory-supply-company-020211/ 2011-02-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-initiates-morquio-syndrome-drug-study-020211/ 2011-02-02T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/bellus-reports-positive-results-of-alzheimers-drug-study-020211/ 2011-02-02T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/kyoto-university-ips-academia-japan-ipierian-sign-ipr-agreement-on-ipsc-technology-020211/ 2011-02-02T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/versus-releases-mobile-application-for-healthcare-rtls-020211/ 2011-02-02T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/eisais-9-month-profit-advances-25-on-higher-drug-revenue-020211/ 2011-02-02T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-q4-revenue-rises-020211/ 2011-02-02T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-q4-revenue-up-6-020211/ 2011-02-02T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-takes-over-tempra-from-bristol-myers-squibb-020211/ 2011-02-02T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/saic-frederick-opts-aphios-to-develop-anticancer-drug-020211/ 2011-02-02T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-aventis-phase-iii-study-of-lixisenatide-meets-primary-endpoint-020211/ 2011-02-02T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/optivia-fda-to-assess-dietary-supplement-role-in-drug-induced-liver-injury-020211/ 2011-02-02T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/nestle-launches-tube-feeding-formula-for-critically-ill-obese-patients-020211/ 2011-02-02T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/apeiron-acquires-rights-to-neuroblastoma-compound-from-merck-020211/ 2011-02-02T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-initiates-european-trial-of-genotyping-technology-020211/ 2011-02-02T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-q4-net-sales-fall-020211/ 2011-02-02T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-therapeutics-enrolls-first-patient-in-its-phase-ii-cancer-vaccine-trial-030211/ 2011-02-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-pay-texas-170m-in-drug-pricing-case-030211/ 2011-02-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-biotec-installs-felten-meswds-production-system-at-its-facility-030211/ 2011-02-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/optimer-releases-fidaxomicin-phase-3-trial-results-030211/ 2011-02-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiogenics-merck-chimie-to-commercialize-magnetic-beads-030211/ 2011-02-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pilgrim-software-to-provide-quality-compliance-solution-to-megadyne-030111/ 2011-02-02T19:13:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-adhd-treatment-wins-health-canada-approval-030211/ 2011-02-02T22:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fera-pharma-introduces-otc-puralube-ophthalmic-ointment-030211/ 2011-02-03T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/egen-receives-fda-orphan-drug-grant-for-ovarian-cancer-drug-030211/ 2011-02-03T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-revenues-up-in-q4-030211/ 2011-02-03T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/us-firm-sues-fda-for-importing-unapproved-lethal-injection-drug-030211/ 2011-02-03T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/raindance-technologies-launches-solution-for-rare-cancer-mutation-detection-030211/ 2011-02-03T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-bristol-myers-squibb-stop-patient-enrollment-for-inspire-trial-030211/ 2011-02-03T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/antisense-receives-approval-to-conduct-cancer-drug-trials-in-korea-taiwan-030211/ 2011-02-03T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/nhs-among-best-in-europe-for-medical-trials-north-west-exemplar-programme-030211/ 2011-02-03T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaceutical-industry-to-face-unprecedented-patent-expiries-evaluatepharma-data-030211/ 2011-02-03T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-establishes-new-plant-to-serve-us-uk-markets-030211/ 2011-02-03T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-receives-complete-response-letter-from-fda-for-gerd-drug-030211/ 2011-02-03T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-doses-first-rheumatoid-arthritis-patient-in-vibex-mtx-clinical-trial-030211/ 2011-02-03T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-reports-net-sales-dip-in-q4-2010-030211/ 2011-02-03T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxo-sells-quest-for-17bn-030211/ 2011-02-03T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cedars-sinai-research-teams-receive-cirm-grants-to-develop-new-techniques-030211/ 2011-02-03T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/welichem-completes-two-phase-ii-clinical-trials-of-cream-for-psoriasis-atopic-dermatitis-030211/ 2011-02-03T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-signs-agreement-with-walter-reed-institute-to-evaluate-neuroprotective-drug-030211/ 2011-02-03T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-adopt-different-research-strategies-to-cut-costs-040211/ 2011-02-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-nine-month-profit-declines-040211/ 2011-02-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dalton-oncovir-sign-manufacturing-services-agreement-040211/ 2011-02-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-posts-fourth-quarter-loss-due-to-restructuring-charges-040211/ 2011-02-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioteam-life-technologies-extend-support-for-ion-torrent-server-040211/ 2011-02-03T18:43:00+00:00 https://www.pharmaceutical-business-review.com/news/nitto-denko-takes-over-avecia-biotechnology-040211/ 2011-02-03T22:17:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-takeda-sign-co-promotion-agreements-for-ra-drugs-in-japan-040211/ 2011-02-03T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-hospira-topotecan-injection-040211/ 2011-02-03T23:00:00+00:00 https://www.pharmaceutical-business-review.com/news/quercegen-gets-fda-gras-notified-status-for-qu995-quercetin-040211/ 2011-02-04T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/derma-sciences-diabetic-ulcer-drug-meets-primary-endpoint-040211/ 2011-02-04T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ampakine-cx1739-improves-sleep-apnea-respiratory-parameters-cortex-040211/ 2011-02-04T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-subsidiary-biovail-to-acquire-zovirax-us-canadian-rights-from-gsk-040211/ 2011-02-04T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-merck-terminate-strategic-alliances-040211/ 2011-02-04T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/shionogi-initiates-patient-enrolment-for-hiv-therapy-040211/ 2011-02-04T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-gastrointestinal-tumour-drug-receives-fda-orphan-drug-designation-040211/ 2011-02-04T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/american-regent-initiates-potassium-phosphates-injection-voluntary-recall-040211/ 2011-02-04T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-partek-join-hands-for-data-analysis-070211/ 2011-02-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-sterile-fill-finish-facility-wins-italian-medicines-agency-approval-070211/ 2011-02-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-debiopharm-partner-to-develop-rnai-based-bladder-cancer-therapies-070211/ 2011-02-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-compound-mor103-gets-us-patent-070211/ 2011-02-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-taj-pharma-launch-gemcitabine-hci-for-injection-in-us-070211/ 2011-02-06T22:13:00+00:00 https://www.pharmaceutical-business-review.com/news/alda-to-purchase-manufacturing-firm-seavan-health-beauty-partnership-070211/ 2011-02-06T22:23:00+00:00 https://www.pharmaceutical-business-review.com/news/stiefel-unveils-panoxyl-acne-formulations-in-us-070211/ 2011-02-06T22:36:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-helps-la-red-health-center-to-build-new-facility-in-sussex-county070211/ 2011-02-06T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/antigen-express-gets-notice-of-allowance-for-ae37-cancer-vaccine-070211/ 2011-02-07T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-dismisses-biovail-lawsuit-against-intelgenx-070211/ 2011-02-07T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-receives-grant-from-iwt-for-drug-discovery-research-programs-070211/ 2011-02-07T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-purchase-consumer-healthcare-business-of-ferrosan-070211/ 2011-02-07T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-focus-on-external-partnerships-for-new-innovations-cost-savings-070211/ 2011-02-07T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-gist-drug-regorafenib-gets-us-fda-orphan-drug-status-070211/ 2011-02-07T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitest-recalls-hydrocodone-bitartrate-acetaminophen-phenobarbital-tablets-070211/ 2011-02-07T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/nyse-amex-accepts-palatin-listing-compliance-plan-070211/ 2011-02-07T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/infant-health-charity-welcomes-fda-approval-of-progesterone-injections-070211/ 2011-02-07T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ecr-pharma-rolls-out-zolpimist-oral-spray-in-us-070211/ 2011-02-07T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/wiley-protocol-idiom-patent-decision-making-process-of-hormone-administration-070211/ 2011-02-07T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-unveils-new-generation-dna-vaccine-delivery-technology-results-070211/ 2011-02-07T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/intelgenx-presents-positive-oral-film-study-results-070211/ 2011-02-07T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/synexus-wins-first-contract-to-conduct-ophthalmology-studies-070211/ 2011-02-07T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-first-drug-to-reduce-preterm-delivery-risk-070211/ 2011-02-07T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-initiates-psoriasis-compound-study-070211/ 2011-02-07T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ab-sciex-arup-labs-partner-to-develop-new-clinical-research-methods-for-hormone-analysis-080211/ 2011-02-07T17:22:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-opens-new-facility-in-us-headquarters-080211/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerion-appoints-new-chief-regulatory-officer-080211/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teradata-releases-dedicated-logical-data-model-for-life-sciences-industry-080211/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basi-2011-first-quarter-revenues-rise-080211/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tufts-university-launches-institute-for-biopharmaceutical-partnerships-website-080211/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cap-n-lock-unveils-new-locking-cap-for-prescription-drugs-080211/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-launches-biothreat-assay-for-plex-id-system-0802011/ 2011-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/selventa-gets-uspto-patent-for-computer-based-storage-system-080211/ 2011-02-07T19:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-receives-notice-letter-of-anda-filing-for-tamiflu-080211/ 2011-02-07T22:21:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-pharma-progenics-in-relistor-worldwide-license-agreement-080211/ 2011-02-07T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-hiv-drug-reyataz-labeling-update-080211/ 2011-02-07T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-receives-fda-approval-for-lung-cancer-drug-us-phase-i-trial-080211/ 2011-02-07T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/epicept-np-1-trial-shows-positive-results-for-chemotherapy-induced-peripheral-neuropathy-080211/ 2011-02-07T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-horiba-form-strategic-alliance-080211/ 2011-02-08T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/remedymd-unveils-comprehensivebmt-for-hematopoietic-stem-cell-transplant-research-080211/ 2011-02-08T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/mtbc-proprietary-ehr-mtbc-emr-v-50-receive-onc-atcb-20112012-certification-080211/ 2011-02-08T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-adds-select-rx-prenatal-vitamin-to-nexa-family-080211/ 2011-02-08T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-secures-facility-to-scale-up-plasma-derived-therapeutics-business-080211/ 2011-02-08T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxo-to-pay-above-250m-to-settle-diabetes-drug-avandia-lawsuits-080211/ 2011-02-08T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/urgentrx-launches-new-heart-attack-drug-in-portable-packets-080211/ 2011-02-08T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-halts-prostate-cancer-drug-trial-080211/ 2011-02-08T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmamar-initiates-solid-tumour-drug-study-080211/ 2011-02-08T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/intellipharmaceutics-retains-doll-consulting-services-080211/ 2011-02-08T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/griffith-laboratories-micocin-bags-health-canada-approval-080211/ 2011-02-08T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-medical-to-open-new-manufacturing-facility-in-costa-rica-080211/ 2011-02-08T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ansaris-receives-milestone-payment-from-ono-pharma-080211/ 2011-02-08T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/triple-s-management-acquires-american-health-for-83m-080211/ 2011-02-08T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-to-provide-contract-manufacturing-service-for-clinical-data-in-us/ 2011-02-08T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-ovarian-cancer-drug-meets-primary-endpoint-080211/ 2011-02-08T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-targacept-initiate-depressive-disorder-drug-phase-2b-trial-080211/ 2011-02-08T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/hgs-gsk-report-sle-drug-study-results-080211/ 2011-02-08T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/jumpstart-ventures-cleveland-clinic-invest-in-sironrx-therapeutics-080211/ 2011-02-08T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-pay-10m-over-prempro-dispute-090211/ 2011-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-nkt-therapeutics-sign-contract-to-develop-nkt-cells-based-therapeutics-090211/ 2011-02-08T22:27:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-receives-eur4m-under-servier-strategic-alliance-090211/ 2011-02-08T22:41:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-receives-us-patent-for-methods-of-preparing-glatiramer-acetate-090211/ 2011-02-08T22:51:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmagap-northern-lipids-to-jointly-develop-cancer-drug-liposomal-delivery-formulation-090211/ 2011-02-08T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-releases-stroke-research-collaboration-findings-090211/ 2011-02-08T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ferndale-pharma-receives-fda-comments-on-prelude-510k-submission-080211/ 2011-02-09T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-in-license-agreement-with-allergan-for-aczone-gel-5-in-canada-090211/ 2011-02-09T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mednet-solutions-unveils-eclinical-solution-enlighten-latest-version-090211/ 2011-02-09T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinnovel-secures-325000-investment-from-ip-group-090211/ 2011-02-09T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-reports-16-rise-in-annual-sales-090211/ 2011-02-09T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-receives-health-canada-notice-of-non-compliance-related-to-feraheme-090211/ 2011-02-09T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-doses-first-patient-in-leukaemia-drug-study-090211/ 2011-02-09T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/rib-x-initiates-antibiotic-drug-trial-090211/ 2011-02-09T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/kalobios-opts-potelligent-chok1sv-cell-line-for-humaneered-antibodies-production-090211/ 2011-02-09T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-boehringer-ingelheim-forge-antibody-based-therapeutics-manufacturing-alliance-090211/ 2011-02-09T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-university-of-washington-receive-us-patent-for-herpes-simplex-vaccine-090211/ 2011-02-09T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-pharma-pdl-biopharma-settle-patent-disputes-090211/ 2011-02-09T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-revises-us-avandia-label-to-include-fda-usage-restrictions-090211/ 2011-02-09T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-gets-cephalon-products-commercial-rights-in-canada-latin-america-090211/ 2011-02-09T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bafetinib-prevents-cancer-related-bone-loss-cytrx-090211/ 2011-02-09T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/r-tech-initiates-hypotrichosis-drug-study-090211/ 2011-02-09T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/hhs-grants-meaningful-use-certification-to-csc-c-suite-emr-solution-100211/ 2011-02-09T18:11:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-favors-watson-in-generic-mucinex-patent-infringement-case-100211/ 2011-02-09T22:09:00+00:00 https://www.pharmaceutical-business-review.com/news/orexigen-adopts-corporate-realignment-100211/ 2011-02-09T22:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-afinitor-extends-progression-free-survival-in-net-patients-radiant-3-study-100211/ 2011-02-09T22:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-to-acquire-larazotide-acetate-assets-from-alba-therapeutics-100211/ 2011-02-09T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pra-to-open-new-offices-in-europe-middle-east-100211/ 2011-02-10T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/mphase-technologies-us-army-sign-3-year-research-agreement-100211/ 2011-02-10T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bioject-to-offer-id-pen-injector-for-intradermal-delivery-studies-100211/ 2011-02-10T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/protect-sells-pain-drugs-patent-portfolio-to-grunenthal-100211/ 2011-02-10T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmetics-recalls-six-otc-products-in-canada-100211/ 2011-02-10T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-eyes-sanofi-aventis-lantus-market-share-100211/ 2011-02-10T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ultratape-unveils-new-label-printing-solution-100211/ 2011-02-10T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/natco-pharma-files-tamiflu-generic-version-anda-for-fda-approval-100211/ 2011-02-10T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-reports-positive-parkinsons-drug-study-results-100211/ 2011-02-10T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/targacept-initiates-two-anti-inflammatory-drug-studies-100211/ 2011-02-10T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-novartis-cancer-drugs-effective-against-rare-pancreatic-tumour-new-study-100211/ 2011-02-10T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/circassia-acquires-airmid-psoriasis-atopic-dermatitis-drug-worldwide-rights-100211/ 2011-02-10T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-biologics-reports-xd-process-technology-results-100211/ 2011-02-10T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ap-pharma-updates-on-apf530-program-100211/ 2011-02-10T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-acquires-kinaxo-biotechnologies/ 2011-02-10T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/geovax-launches-second-clinical-site-to-test-hiv-vaccine-100211/ 2011-02-10T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-receives-fda-clearance-to-initiate-influenza-vaccine-trial-100211/ 2011-02-10T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/merge-healthcare-enters-into-new-contracts-for-clinical-trials-solutions-110211/ 2011-02-10T16:50:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-refiles-single-tablet-regimen-of-truvada-tmc278-nda-with-fda-110211/ 2011-02-10T22:06:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-subsidiary-biovail-acquires-cholestagel-canadian-rights-from-genzyme-110211/ 2011-02-10T22:38:00+00:00 https://www.pharmaceutical-business-review.com/news/covidien-fentanyl-transdermal-system-patch-wins-fda-approval-110211/ 2011-02-10T22:39:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-initiates-hepatitis-c-polymerase-inhibitor-phase-1a-trial-110211/ 2011-02-10T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/intellikine-pkd-foundation-partner-to-advance-pkd-therapies-110211/ 2011-02-10T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/medicis-anacor-form-rd-collaboration-for-acne-treatment-110211/ 2011-02-10T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/nextgen-healthcare-hqm-clients-secure-2m-in-reimbursements-110211/ 2011-02-10T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-reports-net-loss-in-2010-fourth-quarter-110211/ 2011-02-11T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/mpi-tcgrx-partner-to-provide-automated-oral-solid-packaging-solutions-110211/ 2011-02-11T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-to-dyadic-novel-beta-glucosidase-gene-110211/ 2011-02-11T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-acquires-orphatec-cpmp-replacement-therapy-110211/ 2011-02-11T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/qlt-retinoid-drug-receives-ema-positive-opinions-110211/ 2011-02-11T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/scripps-study-deciphers-molecular-mechanism-of-heart-disease-110211/ 2011-02-11T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/genta-initiates-prostate-cancer-drug-trial-110211/ 2011-02-11T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/procertus-biopharm-initiates-radiodermatitis-drug-clinical-trial-110211/ 2011-02-11T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-tries-to-prevent-execution-drug-entry-in-us-110211/ 2011-02-11T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/diamyd-cancer-pain-drug-study-published-on-clinicaltrialsgov-110211/ 2011-02-11T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-medica-treats-first-patient-in-cytomegalovirus-trial-110211/ 2011-02-11T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/nuron-biotech-selects-merck-biomanufacturing-network-110211/ 2011-02-11T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-patent-for-allon-therapeutics-progressive-supranuclear-palsy-drug-110211/ 2011-02-11T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/angiodynamics-unveils-new-morpheus-smart-picc-system-140211/ 2011-02-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-king-pharmaceuticals-acurox-nda-140211/ 2011-02-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/postech-team-develops-pulsatile-on-demand-drug-delivery-device-140211/ 2011-02-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/acc-recommends-boehringer-pradaxa-for-irregular-heartbeat-140211/ 2011-02-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/axcan-acquires-eurand-140211/ 2011-02-13T21:52:00+00:00 https://www.pharmaceutical-business-review.com/news/capsugel-purchases-flextab-technology-140211/ 2011-02-13T22:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-inhibitex-hcv-drug-140211/ 2011-02-13T22:24:00+00:00 https://www.pharmaceutical-business-review.com/news/general-dynamics-tibco-partner-to-offer-hipaa-5010-icd-10-transition-solution-140211/ 2011-02-14T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lucentis-phase-iii-study-meets-primary-endpoint-genentech-140211/ 2011-02-14T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/shamla-pharma-industries-to-establish-manufacturing-facility-at-kaec-industrial-valley-140211/ 2011-02-14T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/new-approach-to-treat-diabetes-without-insulin-childrens-hospital-study-140211/ 2011-02-14T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-discuss-with-fda-over-contraceptive-pill-wider-access-140211/ 2011-02-14T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/home-based-billers-partner-with-med-datacare-pros-healthcare-network-140211/ 2011-02-14T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-pharmaceuticals-reports-positive-testosterone-gel-phase-iii-safety-data-140211/ 2011-02-14T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/qps-acquires-taiwan-based-toxicology-unit-of-dcb-140211/ 2011-02-14T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/panacea-biotec-to-unveil-generic-breast-cancer-drug-pacliall-140211/ 2011-02-14T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/renovo-scar-revision-drug-juvista-fails-to-meet-primary-endpoint-140211/ 2011-02-14T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-janssen-collaborate-to-combat-dengue-virus-infection-140211/ 2011-02-14T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-settles-rogaine-foam-patent-litigation-140211/ 2011-02-14T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-is-pharma-in-talks-to-form-pan-european-specialty-pharma-company-140211/ 2011-02-14T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/adventrx-inks-agreement-to-acquire-synthrx-140211/ 2011-02-14T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/who-allows-crucell-to-sell-childhood-vaccines-to-unicef-140211/ 2011-02-14T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-to-raise-funds-to-share-drug-development-costs-140211/ 2011-02-14T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-reports-positive-pancreatic-cancer-drug-study-results-150211/ 2011-02-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/identigene-launches-dna-paternity-test-kits-in-new-york-150211/ 2011-02-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/doro-partners-with-myglucohealth-medixine-150211/ 2011-02-14T21:13:00+00:00 https://www.pharmaceutical-business-review.com/news/new-england-biolabs-expands-pcr-reagents-product-line-150211/ 2011-02-14T22:08:00+00:00